These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14627269)

  • 1. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
    Schuster R; Lee SJ; Rink D
    Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
    Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
    Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa: a universal hemostatic agent?
    Lloyd JV; Joist JH
    Curr Hematol Rep; 2002 Sep; 1(1):19-26. PubMed ID: 12901121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of life-threatening bleeding in obstetrics and gynaecology --NovoSeven (recombinant factor VIIa)].
    Nikolov A; Dimitrov A; Tanchev S; Platikanov V; Nacheva A; Gateva Zh; Gerganova A
    Akush Ginekol (Sofiia); 2005; 44(5):39-44. PubMed ID: 16313053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
    Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
    Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa is a pan-hemostatic agent?
    Aledort LM
    Thromb Haemost; 2000 May; 83(5):637-8. PubMed ID: 10823252
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant activated factor VII.
    Celkan T; Alhaj S; Civilibal M; Elicevik M
    Pediatr Hematol Oncol; 2007 Mar; 24(2):117-21. PubMed ID: 17454777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recombinant activated factor VIIa for treatment of traumatic liver rupture].
    Leidinger W; Meierhofer JN; Woelfel R
    Anaesthesist; 2006 Aug; 55(8):868-72. PubMed ID: 16649014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
    Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative use of recombinant activated factor VII (rFVIIa).
    De Gasperi A
    Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.